[1]
T. Blicharski, I. Sowa, M. Strzemski, W. Szwerc, and A. Majewski, “Inhibition of RANKL a key mediator of osteoclast formation – new opportunities in osteoporosis treatment”, Curr. Issues Pharm. Med. Sci., vol. 24, no. 1, pp. 179–185, Apr. 2025, Accessed: Jun. 08, 2025. [Online]. Available: https://czasopisma.umlub.pl/curipms/article/view/2993